FDA label
What is prasugrel used for?
The FDA-approved uses of prasugrel, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for prasugrel lists this use: Acute Coronary Syndrome.
Run it in Rivvi
Which 2027 plans near you dropped or restricted prasugrel?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Prasugrel, tablet, film coated
Indications and Usage, quoted from the label by Apotex Corp. (ANDA205897). Cross-references to other label sections are left out.
Acute Coronary Syndrome
Prasugrel tablet is indicated to reduce the rate of thrombotic cardiovascular (CV) events (including stent thrombosis) in patients with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI) as follows:
- Patients with unstable angina (UA) or non-ST-elevation myocardial infarction (NSTEMI).
- Patients with ST-elevation myocardial infarction (STEMI) when managed with primary or delayed PCI.
Prasugrel tablet has been shown to reduce the rate of a combined endpoint of cardiovascular death, nonfatal myocardial infarction (MI), or nonfatal stroke compared to clopidogrel. The difference between treatments was driven predominantly by MI, with no difference on strokes and little difference on CV death.
Source: DailyMed label, set id f51e64e0-f556-65d0-a876-fb709aaeefea, version 9, effective April 8, 2026. NDC 60505-4642, one of 19 listings for this product.
Questions
What is prasugrel used for?
The FDA label for prasugrel lists this use: Acute Coronary Syndrome.
What drug class is prasugrel?
FDA lists prasugrel in the P2Y12 Platelet Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.